During the last decade we can see how Indian Pharma industry has taken a completely new direction which is very similar to the direction of IT industry. The focus from being essentially domestic is now moving to international. This has made Pharma 4.0 (Industry 4.0 applied to pharma Industry) imperative to for the industry to survive and stay relevant.
Hence, Technologies like smart manufacturing with AI, IoT and complete organisational operation data integration are now a life saver for these life savers. Ecubix has come up with a fabulous answer to this challenge. Effectivity in application of this technology and making it a part of company culture will define the success and survival for the next generation of pharmaceutical manufacturing.
On positive front Indian Pharma industry stands on the cusp of two definite opportunities. The upsurge in demand for drugs usage for Cancer, Hypertension, Diabetes etc. (Between 35% to 70% Jump in certain areas) and to exploit the vacuum created by US sanctioned markets which are increasing and for Pharma they are looking towards Indian companies. Also cost of developing drugs going up opens reasonable cost of production for 100s of fellow developing nations.
Hence the Industry is to face ever increasing competition, higher production requirements, and a stricter regulatory environment which will put a huge pressure on pharma manufacturers to optimise production.
Join our strategic and Insightful Roundtable that would virtually bring senior professionals across the pharmaceutical industry to explore the best strategies & practices on How the emerging technologies that are brought together by Ecubix Digi pharma, characterizing Industry 4.0—from connectivity to advanced analytics and automation—have the potential to revolutionize every element of pharma-manufacturing labs.
Presenting Partner
ecubix owned by Value Chain Solutions (India) Pvt. Ltd. ecubix provide smart solutions for Business Transformation in the area of manufacturing, supply chain, sales & Infrastructure services. Our solutions offer Digital Enterprise, Industrial IoT, Data Science & Analytics to clients worldwide. Process efficiency & Real-time actionable insights to optimize and transform your business.
We help businesses optimize their efficiency, minimize operational costs, and scale rapidly with our smart, AI-driven industry 4.0 solutions that are easy to use and deploy.
Visit us at www.ecubix.com
Roundtable will focus on
Enable Regulatory Compliance
Strengthen the Total Quality System in Medicine produced
Identify process parameters to enable "Golden Batches" in the Production cycle
Understand real-time production monitoring with predictive ability to Identify faults and failure.
Understand Regulatory requirements for Data Integrity
Dignitaries attending
CEO, COO, CTO, CIO, CDO, Senior Vice President, Vice President & Heads of
Production
Compliance Head
QA Head
Technology
Digital Transformation
Business Excellence
Regulatory
Our Speakers
Pinal Shah
Head QC
Ipca Laboratories Limited
Yagiz Aydemir
Head of Digital Marketing & Omnichannel Excellence
Sanofi
Gresh Kumar
Head Operational Excellence
Syngene International Ltd
Kiran Das
Director – Corporate Affairs & Business Strategy
Pulse Pharmaceuticals
Anup Garg
Lead Marcom
Value Chain Solution (India) Pvt. Ltd.
Hrisheekesh Sabnis
Head of Business Development
Aarti Industries Ltd.
Agenda
3:30 PM – Opening Remarks
3:35 PM – Pharma 4.0: Navigating the Regulatory and Compliance challenge
Session focus:
- Unlocking the dynamics of current regulations and Quality standards
- Decoding Regulatory Trends and Developments in the Pharmaceutical Industry.
- Use of Quality Management Systems (QMS) for Validation
- Flexible production’, a site’s ability to accommodate changes in production demands
- ‘Entering new domains’, having the ability to quickly absorb knowledge to implement new practices.
Session By Ecubix
3:55 PM – Roundtable on Preparing for the smart factories of the future – The Path to a Digital Transformation
India’s pharmaceutical industry has grown in confidence and is firmly moving on an accelerated growth path. The future looks really bright and promising.
- Digitization, automation, and online testing: The future of pharmaceutical quality control.
- Restructure future-ready quality matrix
- New business models and ecosystems are challenging the current way of business
- USFDA’s perception for the 21st-century pharmaceutical quality manufacturing requires effective, acute, and flexible production that faithfully generates high-quality drug